- Corporate Officers - A
- Afeyan Noubar
Insider Trading History of Afeyan Noubar
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Afeyan Noubar since 2006.
This trader's CIK number is 1222012.
At the time of last reporting, Afeyan Noubar was the Officer of Moderna, Inc.. (stock ticker symbol MRNA).
Also see all insider trading activities at Moderna, Inc..
Note that in the past
AFEYAN NOUBAR also reported insider trading activities as an insider of the following companies:
Insider Activities at Moderna, Inc. (MRNA)
Insider Activities at Evelo Biosciences, Inc. (EVLO)
Insider Activities at Sana Biotechnology, Inc. (SANA)
Insider Activities at Omega Therapeutics, Inc. (OMGA)
Insider Activities at Codiak Biosciences, Inc. (CDAK)
Insider Activities at Seres Therapeutics, Inc. (MCRB)
Insider Activities at Axcella Health Inc. (AXLA)
Insider Activities at Rubius Therapeutics, Inc. (RUBY)
Insider Activities at Kaleido Biosciences, Inc. (KLDO)
Insider Activities at Foghorn Therapeutics Inc. (FHTX)
Insider Activities at Bg Medicine, Inc. (BGMD)
Insider Activities at Receptos, Inc. (RCPT)
Insider Activities at Bind Therapeutics, Inc (BIND)
Insider Activities at Helicos Biosciences Corp (HLCS)
Insider Activities at Agenus Inc (AGEN)
Yearly summary of insider trading at Kaleido Biosciences, Inc. (KLDO) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | KLDO | 215,000 | $2,472,500 | 0 | $0 | 0 | $0 |
| 2020 | KLDO | 2,000,000 | $15,000,000 | 0 | $0 | 0 | $0 |
| 2019 | KLDO | 933,333 | $13,999,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Evelo Biosciences, Inc. (EVLO) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | EVLO | 5,411,255 | $12,499,999 | 0 | $0 | 0 | $0 |
| 2022 | EVLO | 27,397,259 | $39,999,998 | 0 | $0 | 0 | $0 |
| 2021 | EVLO | 130,000 | $1,950,000 | 0 | $0 | 0 | $0 |
| 2020 | EVLO | 4,666,666 | $17,499,997 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Axcella Health Inc. (AXLA) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | AXLA | 6,319,371 | $12,069,998 | 0 | $0 | 0 | $0 |
| 2020 | AXLA | 3,800,000 | $18,050,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bg Medicine, Inc. (BGMD) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | BGMD | 0 | $0 | 46,438 | $26,005 | 0 | $0 |
Yearly summary of insider trading at Rubius Therapeutics, Inc. (RUBY) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | RUBY | 210,000 | $6,090,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Seres Therapeutics, Inc. (MCRB) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | MCRB | 8,738,243 | $27,525,465 | 0 | $0 | 0 | $0 |
| 2019 | MCRB | 8,888,888 | $19,999,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Agenus Inc (AGEN) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | AGEN | 0 | $0 | 5,000 | $9,755 | 0 | $0 |
Yearly summary of insider trading at Moderna, Inc. (MRNA) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | MRNA | 0 | $0 | 507,832 | $67,507,060 | 0 | $0 |
| 2023 | MRNA | 0 | $0 | 385,000 | $49,144,494 | 0 | $0 |
| 2022 | MRNA | 0 | $0 | 610,000 | $86,711,999 | 703 | $0 |
| 2021 | MRNA | 0 | $0 | 10,290,906 | $1,448,485,975 | 0 | $0 |
| 2020 | MRNA | 0 | $0 | 1,000,000 | $69,583,500 | 0 | $0 |
Yearly summary of insider trading at Helicos Biosciences Corp (HLCS) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | HLCS | 242,931 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bind Therapeutics, Inc (BIND) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | BIND | 20,000 | $300,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Foghorn Therapeutics Inc. (FHTX) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | FHTX | 150,000 | $2,400,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Codiak Biosciences, Inc. (CDAK) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | CDAK | 933,333 | $0 | 0 | $0 | 0 | $0 |
| 2020 | CDAK | 165,000 | $2,475,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sana Biotechnology, Inc. (SANA) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | SANA | 0 | $0 | 949,000 | $6,060,119 | 0 | $0 |
Yearly summary of insider trading at Receptos, Inc. (RCPT) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | RCPT | 107,142 | $1,499,988 | 230,787 | $5,736,652 | 0 | $0 |
Yearly summary of insider trading at Omega Therapeutics, Inc. (OMGA) by Afeyan Noubar
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | OMGA | 3,323,310 | $19,208,731 | 0 | $0 | 0 | $0 |
| 2021 | OMGA | 1,176,469 | $19,999,973 | 0 | $0 | 0 | $0 |
Insider trading activities at 15 companies by Afeyan Noubar:
1. Kaleido Biosciences, Inc. (KLDO)
2. Evelo Biosciences, Inc. (EVLO)
3. Axcella Health Inc. (AXLA)
4. Bg Medicine, Inc. (BGMD)
5. Rubius Therapeutics, Inc. (RUBY)
6. Seres Therapeutics, Inc. (MCRB)
7. Agenus Inc (AGEN)
8. Moderna, Inc. (MRNA)
9. Helicos Biosciences Corp (HLCS)
10. Bind Therapeutics, Inc (BIND)
11. Foghorn Therapeutics Inc. (FHTX)
12. Codiak Biosciences, Inc. (CDAK)
13. Sana Biotechnology, Inc. (SANA)
14. Receptos, Inc. (RCPT)
15. Omega Therapeutics, Inc. (OMGA)
Table 1. Insider trading of Kaleido Biosciences, Inc. (KLDO) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-02-08 | KLDO | Buy | 215,000 | 11.50 | 2,472,500 |
| 2020-06-04 | KLDO | Buy | 2,000,000 | 7.50 | 15,000,000 |
| 2019-03-04 | KLDO | Buy | 933,333 | 15.00 | 13,999,995 |
Table 2. Insider trading of Evelo Biosciences, Inc. (EVLO) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-07-11 | EVLO | Buy | 5,411,255 | 2.31 | 12,499,999 |
| 2022-05-27 | EVLO | Buy | 27,397,259 | 1.46 | 39,999,998 |
| 2021-02-02 | EVLO | Buy | 130,000 | 15.00 | 1,950,000 |
| 2020-06-29 | EVLO | Buy | 4,666,666 | 3.75 | 17,499,997 |
Table 3. Insider trading of Axcella Health Inc. (AXLA) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-03-16 | AXLA | Buy | 6,319,371 | 1.91 | 12,069,998 |
| 2020-05-18 | AXLA | Buy | 3,800,000 | 4.75 | 18,050,000 |
Table 4. Insider trading of Bg Medicine, Inc. (BGMD) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-12-09 | BGMD | Sale | 46,438 | .56 | 26,005 |
Table 5. Insider trading of Rubius Therapeutics, Inc. (RUBY) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-19 | RUBY | Buy | 210,000 | 29.00 | 6,090,000 |
Table 6. Insider trading of Seres Therapeutics, Inc. (MCRB) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-07-05 | MCRB | Buy | 8,738,243 | 3.15 | 27,525,465 |
| 2019-06-18 | MCRB | Buy | 8,888,888 | 2.25 | 19,999,998 |
Table 7. Insider trading of Agenus Inc (AGEN) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-12-14 | AGEN | Sale | 5,000 | 1.95 | 9,755 |
Table 8. Insider trading of Moderna, Inc. (MRNA) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-07-31 | MRNA | Sale | 15,000 | 120.33 | 1,804,875 |
| 2024-07-24 | MRNA | Sale | 15,000 | 117.72 | 1,765,830 |
| 2024-07-17 | MRNA | Sale | 15,000 | 122.75 | 1,841,175 |
| 2024-07-10 | MRNA | Sale | 15,000 | 118.05 | 1,770,750 |
| 2024-06-26 | MRNA | Sale | 15,000 | 127.95 | 1,919,280 |
| 2024-06-18 | MRNA | Sale | 15,000 | 134.30 | 2,014,545 |
| 2024-06-12 | MRNA | Sale | 15,000 | 146.92 | 2,203,785 |
| 2024-06-11 | MRNA | Sale | 202,832 | 148.85 | 30,191,340 |
| 2024-06-05 | MRNA | Sale | 15,000 | 150.66 | 2,259,840 |
| 2024-05-29 | MRNA | Sale | 20,000 | 144.42 | 2,888,440 |
| 2024-05-22 | MRNA | Sale | 15,000 | 154.27 | 2,314,050 |
| 2024-05-15 | MRNA | Sale | 15,000 | 127.55 | 1,913,250 |
| 2024-05-08 | MRNA | Sale | 15,000 | 121.34 | 1,820,130 |
| 2024-05-01 | MRNA | Sale | 15,000 | 111.57 | 1,673,520 |
| 2024-04-24 | MRNA | Sale | 15,000 | 108.60 | 1,629,015 |
| 2024-04-17 | MRNA | Sale | 15,000 | 103.76 | 1,556,400 |
| 2024-04-10 | MRNA | Sale | 15,000 | 107.96 | 1,619,370 |
| 2024-04-03 | MRNA | Sale | 15,000 | 101.33 | 1,519,905 |
| 2024-03-27 | MRNA | Sale | 15,000 | 108.38 | 1,625,745 |
| 2024-03-20 | MRNA | Sale | 15,000 | 102.12 | 1,531,845 |
| 2024-03-13 | MRNA | Sale | 15,000 | 109.60 | 1,643,970 |
| 2023-11-01 | MRNA | Sale | 10,000 | 75.73 | 757,330 |
| 2023-10-25 | MRNA | Sale | 10,000 | 77.49 | 774,940 |
| 2023-10-11 | MRNA | Sale | 15,000 | 104.26 | 1,563,870 |
| 2023-10-04 | MRNA | Sale | 15,000 | 102.05 | 1,530,735 |
| 2023-09-27 | MRNA | Sale | 10,000 | 99.37 | 993,700 |
| 2023-09-20 | MRNA | Sale | 15,000 | 104.90 | 1,573,485 |
| 2023-09-13 | MRNA | Sale | 15,000 | 111.17 | 1,667,520 |
| 2023-09-06 | MRNA | Sale | 15,000 | 108.08 | 1,621,260 |
| 2023-08-30 | MRNA | Sale | 15,000 | 115.96 | 1,739,430 |
| 2023-08-23 | MRNA | Sale | 15,000 | 114.78 | 1,721,715 |
| 2023-08-16 | MRNA | Sale | 10,000 | 97.71 | 977,060 |
| 2023-08-02 | MRNA | Sale | 15,000 | 112.08 | 1,681,170 |
| 2023-07-26 | MRNA | Sale | 15,000 | 120.47 | 1,806,990 |
| 2023-07-19 | MRNA | Sale | 15,000 | 125.16 | 1,877,385 |
| 2023-07-12 | MRNA | Sale | 15,000 | 125.91 | 1,888,575 |
| 2023-07-05 | MRNA | Sale | 15,000 | 125.84 | 1,887,585 |
| 2023-06-28 | MRNA | Sale | 15,000 | 121.33 | 1,819,875 |
| 2023-06-21 | MRNA | Sale | 15,000 | 122.44 | 1,836,675 |
| 2023-06-14 | MRNA | Sale | 15,000 | 126.73 | 1,901,025 |
| 2023-06-07 | MRNA | Sale | 15,000 | 126.17 | 1,892,610 |
| 2023-05-31 | MRNA | Sale | 15,000 | 127.70 | 1,915,440 |
| 2023-03-01 | MRNA | Sale | 10,000 | 139.00 | 1,390,000 |
| 2023-02-22 | MRNA | Sale | 10,000 | 160.35 | 1,603,500 |
| 2023-02-15 | MRNA | Sale | 10,000 | 173.17 | 1,731,699 |
| 2023-02-08 | MRNA | Sale | 20,000 | 166.92 | 3,338,420 |
| 2023-01-25 | MRNA | Sale | 10,000 | 194.33 | 1,943,300 |
| 2023-01-18 | MRNA | Sale | 10,000 | 200.20 | 2,002,000 |
| 2023-01-11 | MRNA | Sale | 10,000 | 188.57 | 1,885,700 |
| 2023-01-04 | MRNA | Sale | 10,000 | 182.15 | 1,821,500 |
| 2022-12-21 | MRNA | Sale | 10,000 | 201.70 | 2,017,000 |
| 2022-12-07 | MRNA | Sale | 10,000 | 172.16 | 1,721,600 |
| 2022-11-30 | MRNA | Sale | 10,000 | 173.52 | 1,735,200 |
| 2022-11-30 | MRNA | Sale | 10,000 | 173.52 | 1,735,200 |
| 2022-11-23 | MRNA | Sale | 10,000 | 178.01 | 1,780,100 |
| 2022-11-16 | MRNA | Sale | 10,000 | 184.25 | 1,842,500 |
| 2022-11-02 | MRNA | Sale | 10,000 | 154.20 | 1,542,000 |
| 2022-10-26 | MRNA | Sale | 10,000 | 137.25 | 1,372,500 |
| 2022-10-19 | MRNA | Sale | 10,000 | 132.50 | 1,325,000 |
| 2022-10-12 | MRNA | Sale | 10,000 | 135.36 | 1,353,600 |
| 2022-10-05 | MRNA | Sale | 10,000 | 122.40 | 1,224,000 |
| 2022-09-28 | MRNA | Sale | 10,000 | 123.58 | 1,235,800 |
| 2022-09-21 | MRNA | Sale | 10,000 | 130.37 | 1,303,700 |
| 2022-09-14 | MRNA | Sale | 10,000 | 134.00 | 1,340,000 |
| 2022-09-07 | MRNA | Sale | 10,000 | 129.68 | 1,296,800 |
| 2022-08-31 | MRNA | Sale | 10,000 | 136.95 | 1,369,500 |
| 2022-08-17 | MRNA | Sale | 10,000 | 165.24 | 1,652,400 |
| 2022-08-10 | MRNA | Sale | 10,000 | 174.09 | 1,740,900 |
| 2022-08-03 | MRNA | Sale | 10,000 | 167.99 | 1,679,900 |
| 2022-07-27 | MRNA | Sale | 10,000 | 161.00 | 1,610,000 |
| 2022-07-20 | MRNA | Sale | 10,000 | 167.00 | 1,670,000 |
| 2022-07-13 | MRNA | Sale | 10,000 | 168.88 | 1,688,800 |
| 2022-07-13 | MRNA | Sale | 10,000 | 168.88 | 1,688,800 |
| 2022-07-06 | MRNA | Sale | 10,000 | 154.85 | 1,548,500 |
| 2022-06-29 | MRNA | Sale | 10,000 | 140.47 | 1,404,700 |
| 2022-06-22 | MRNA | Sale | 10,000 | 127.69 | 1,276,900 |
| 2022-06-08 | MRNA | Sale | 10,000 | 147.47 | 1,474,700 |
| 2022-06-01 | MRNA | Sale | 10,000 | 146.31 | 1,463,100 |
| 2022-05-25 | MRNA | Sale | 10,000 | 130.80 | 1,308,000 |
| 2022-05-18 | MRNA | Sale | 10,000 | 138.38 | 1,383,800 |
| 2022-05-11 | MRNA | Sale | 10,000 | 130.74 | 1,307,400 |
| 2022-05-12 | MRNA | Sale | 200,000 | 130.78 | 26,156,800 |
| 2022-05-13 | MRNA | Sale | 100,000 | 134.63 | 13,462,799 |
| 2022-04-28 | MRNA | Option Ex | 703 | .00 | 0 |
| 2021-03-30 | MRNA | Sale | 2,112,795 | 120.82 | 255,267,891 |
| 2021-03-29 | MRNA | Sale | 1,635,122 | 126.98 | 207,631,061 |
| 2021-03-31 | MRNA | Sale | 4,888 | 121.07 | 591,809 |
| 2021-02-22 | MRNA | Sale | 1,836,766 | 164.70 | 302,515,360 |
| 2021-02-23 | MRNA | Sale | 2,947,638 | 144.01 | 424,495,243 |
| 2021-02-24 | MRNA | Sale | 1,753,697 | 147.11 | 257,984,611 |
| 2020-05-22 | MRNA | Sale | 500,000 | 69.81 | 34,905,500 |
| 2020-05-21 | MRNA | Sale | 500,000 | 69.36 | 34,678,000 |
Table 9. Insider trading of Helicos Biosciences Corp (HLCS) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-09-18 | HLCS | Buy | 242,931 | .00 | 0 |
Table 10. Insider trading of Bind Therapeutics, Inc (BIND) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-09-25 | BIND | Buy | 20,000 | 15.00 | 300,000 |
Table 11. Insider trading of Foghorn Therapeutics Inc. (FHTX) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-10-27 | FHTX | Buy | 150,000 | 16.00 | 2,400,000 |
Table 12. Insider trading of Codiak Biosciences, Inc. (CDAK) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-15 | CDAK | Buy | 933,333 | .00 | 0 |
| 2020-10-16 | CDAK | Buy | 165,000 | 15.00 | 2,475,000 |
Table 13. Insider trading of Sana Biotechnology, Inc. (SANA) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-07 | SANA | Sale | 200,000 | 6.24 | 1,248,000 |
| 2023-06-06 | SANA | Sale | 203,758 | 6.31 | 1,284,897 |
| 2023-05-25 | SANA | Sale | 115,372 | 6.35 | 732,842 |
| 2023-05-24 | SANA | Sale | 347,870 | 6.57 | 2,283,766 |
| 2023-05-26 | SANA | Sale | 82,000 | 6.23 | 510,614 |
Table 14. Insider trading of Receptos, Inc. (RCPT) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-11-14 | RCPT | Sale | 155,583 | 25.03 | 3,894,242 |
| 2013-11-18 | RCPT | Sale | 20,300 | 24.09 | 489,027 |
| 2013-11-15 | RCPT | Sale | 54,904 | 24.65 | 1,353,383 |
| 2013-05-14 | RCPT | Buy | 107,142 | 14.00 | 1,499,988 |
Table 15. Insider trading of Omega Therapeutics, Inc. (OMGA) by Afeyan Noubar
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-02-27 | OMGA | Buy | 3,323,310 | 5.78 | 19,208,731 |
| 2021-08-03 | OMGA | Buy | 1,176,469 | 17.00 | 19,999,973 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Afeyan Noubar
(Officer of Moderna, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.